Rockefeller Capital Management
BNGO icon

Rockefeller Capital Management’s Bionano Genomics BNGO Stock Holding History

Rockefeller Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10
Closed -$8K – 2207
2022
Q4 		$8K Buy
10
+3
+43% +$3.77K ﹤0.01% 3161
2022
Q3 		$7K Buy
+7
New +$9.25K ﹤0.01% 3216
2022
Q2 		– Sell
-1
Closed -$1K – 4103
2022
Q1 		$1K Hold
1
– – ﹤0.01% 3702
2021
Q4 		$2K Hold
1
– – ﹤0.01% 3514
2021
Q3 		$3K Buy
+1
New +$3.5K ﹤0.01% 3315
2021
Q2 		– Sell
-1
Closed -$3K – 3438
2021
Q1 		$3K Buy
+1
New +$5.64K ﹤0.01% 3003

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rockefeller Capital Management's BNGO Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Bionano Genomics (BNGO) in Q1 2023, closing a stake of 10 shares — an estimated $8K sold.

Rockefeller Capital Management first reported a position in BNGO in Q1 2021 and held it in 6 quarters. The position peaked at $8K in Q4 2022. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Bionano Genomics position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 10 Bionano Genomics shares in Q1 2023, an estimated $8K.
  • Rockefeller Capital Management first reported a position in Bionano Genomics in Q1 2021 and held it in 6 quarters.
  • Rockefeller Capital Management's Bionano Genomics position peaked at $8K in Q4 2022.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.